Epidemiology and Survival of Patients With Optic Pathway Gliomas: A Population-Based Analysis
Authors:
Open Access
- 11 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 789856
Abstract
Background: We aimed to analyze the epidemiology and outcomes of pediatric patients and adult patients with optic pathway gliomas in the United States using a population-based method. Methods: Data for patients with optic pathway gliomas diagnosed between 2000 and 2018 were extracted from the SEER database. We divided the patients into a pediatric group and an adult group. Descriptive analyses were conducted to analyze demographic and clinical characteristics and treatment. We used the chi-square test to evaluate differences between pediatric and adult patients with optic pathway gliomas. The possible prognostic indicators were analyzed by Kaplan–Meier curves and Cox proportional hazards models. Results: Optic pathway gliomas represented 86.6% of all lesions originating from the optic pathway. In total, 1257 cases of optic pathway gliomas were included in our study. Pediatric patients accounted for 83.7% in this cohort, and most of the patients were diagnosed at 1-4 years old. Chemotherapy was chosen most often for pediatric patients, but radiation therapy was chosen most often for adult patients. Pilocytic astrocytoma accounted for 59.1% of pediatric patients and 37.5% of adult patients. The overall survival (OS) rates were 94.8% 5 years after diagnosis and 93.0% 10 years after diagnosis. Survival analysis showed that surgery, radiation and chemotherapy did not help patients obtain a better prognosis. Overall, pediatric patients had a better prognosis. Conclusion: Optic pathway gliomas are relatively rare lesions with good prognosis. They mostly affect children, and pilocytic astrocytoma is the most common histological diagnosis. Highly individualized treatment is essential for such patients.Keywords
This publication has 16 references indexed in Scilit:
- Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1Journal of Neuro-Oncology, 2016
- Long‐term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictiveCancer, 2015
- GliomaNature Reviews Disease Primers, 2015
- Optic nerve glioma: an updateInternational Ophthalmology, 2014
- Low-Dose Cisplatin-Etoposide Regimen for Patients with Optic Pathway Glioma: A Report of Four Cases and Literature ReviewNeuropediatrics, 2013
- Visual Outcomes in Pediatric Optic Pathway Glioma After Conformal Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidenceEuropean Journal of Cancer, 2010
- Prognostic factors for progression of childhood optic pathway glioma: A systematic reviewEuropean Journal of Cancer, 2006
- Optic pathway gliomasPediatric Blood & Cancer, 2006
- Natural history and clinical management of optic pathway gliomaBritish Journal Of Neurosurgery, 2003